Non contraceptive health benefits of intrauterine devices: A systematic review

被引:106
作者
Hubacher, D
Grimes, DA
机构
[1] Family Hlth Int, VP Biomed Affairs, Res Triangle Pk, NC 27709 USA
[2] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA
关键词
D O I
10.1097/00006254-200202000-00024
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Most women and their clinicians are unaware that IUDs confer important noncontraceptive health benefits. This review summarizes the evidence from published articles on this topic. We conducted a series of systematic literature searches to identify articles on the noncontraceptive health benefits of IUD use. We reviewed the potentially pertinent ones for content, grouped them according to type of IUD, and evaluated them using the U.S. Preventive Services Task Force rating system. Over 500 titles were identified and several hundred abstracts were reviewed. Use of nonhormonal IUDs (plastic and copper) was associated with a decrease in endometrial cancer. The levonorgestrel intrauterine system can treat a variety of gynecological disorders, including menorrhagia and anemia. The levonorgestrel system has also been used successfully as part of hormone replacement therapy, as adjuvant therapy with tamoxifen, and as an alternative to hysterectomy for women with bleeding problems. Like oral contraceptives, intrauterine contraceptives confer important noncontraceptive health benefits. Target Audience: Obstetricians & Gynecologists, Family Physicians Learning Objectives: After completion of this article, the reader will be able to describe the currently marketed IUDs in the U.S., to summarize the current literature about the non contraceptive benefits of IUD use, and to list the noncontraceptive benefits of IUD use.
引用
收藏
页码:120 / 128
页数:9
相关论文
共 73 条
[61]   Intrauterine device use and endometrial cancer risk [J].
Sturgeon, SR ;
Brinton, LA ;
Berman, ML ;
Mortel, R ;
Twiggs, LB ;
Barrett, RJ ;
Wilbanks, GD ;
Lurain, JR .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1997, 26 (03) :496-500
[62]   Three-year follow-up of the use of a levonorgestrel-releasing intrauterine system in hormone replacement therapy [J].
Suhonen, S ;
Holmstrom, T ;
Lahteenmaki, P .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1997, 76 (02) :145-150
[63]  
SUHONEN SP, 1995, FERTIL STERIL, V63, P336
[64]   SUSTAINED-RELEASE ESTRADIOL IMPLANTS AND A LEVONORGESTREL-RELEASING INTRAUTERINE-DEVICE IN HORMONE REPLACEMENT THERAPY [J].
SUHONEN, SP ;
ALLONEN, HO ;
LAHTEENMAKI, P .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (02) :562-567
[65]   The levonorgestrel intrauterine system in menopausal hormone replacement therapy: five-year experience [J].
Suvanto-Luukkonen, E ;
Kauppila, A .
FERTILITY AND STERILITY, 1999, 72 (01) :161-163
[66]   Percutaneous estradiol gel with an intrauterine levonorgestrel releasing device or natural progesterone in hormone replacement therapy [J].
SuvantoLuukkonen, E ;
Sundstrom, H ;
Penttinen, J ;
Laara, E ;
Pramila, S ;
Kauppila, A .
MATURITAS, 1997, 26 (03) :211-217
[67]   LEVONORGESTREL INTRAUTERINE-DEVICE IN THE TREATMENT OF MENORRHAGIA IN CHINESE WOMEN - EFFICACY VERSUS ACCEPTABILITY [J].
TANG, GWK ;
LO, SST .
CONTRACEPTION, 1995, 51 (04) :231-235
[68]  
THOMAS DB, 1991, INT J CANCER, V49, P186
[69]   PROTECTIVE EFFECT OF INTRAUTERINE RELEASE OF LEVONORGESTREL ON PELVIC INFECTION - 3 YEARS COMPARATIVE EXPERIENCE OF LEVONORGESTREL-RELEASING AND COPPER-RELEASING INTRAUTERINE-DEVICES [J].
TOIVONEN, J ;
LUUKKAINEN, T ;
ALLONEN, H .
OBSTETRICS AND GYNECOLOGY, 1991, 77 (02) :261-264
[70]  
TRIEMAN K, IUDS UPDATE POPULATI, V6